Drugs / SOM230 LAR
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02021942 | Mar 2012 → Oct 2015 | thymoma | Prof. Dr. Berthold Schalke | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SOM230 LAR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02021942 ↗ |
| Route | Intramuscular | “administered i.m.” NCT02021942 ↗ |